These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27759595)

  • 1. Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial Cancers: A National Cancer Database Analysis.
    McGunigal M; Liu J; Kalir T; Chadha M; Gupta V
    Int J Gynecol Cancer; 2017 Jan; 27(1):85-92. PubMed ID: 27759595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
    Page BR; Pappas L; Cooke EW; Gaffney DK
    Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
    Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
    Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
    Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
    Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers.
    Hamilton CA; Cheung MK; Osann K; Chen L; Teng NN; Longacre TA; Powell MA; Hendrickson MR; Kapp DS; Chan JK
    Br J Cancer; 2006 Mar; 94(5):642-6. PubMed ID: 16495918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
    Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
    Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
    Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
    Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma.
    Kim A; Schreiber D; Rineer J; Choi K; Rotman M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e639-44. PubMed ID: 21507584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.
    Matthews RP; Hutchinson-Colas J; Maiman M; Fruchter RG; Gates EJ; Gibbon D; Remy JC; Sedlis A
    Gynecol Oncol; 1997 May; 65(2):206-12. PubMed ID: 9159326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
    Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.
    Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB
    J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
    Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
    Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
    Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.